Cover Image

Duration of sustained remission after treatment by induction with exclusive enteral nutrition and azathioprine in patients with Crohn's disease

Saved in:

Bibliographic Details
Main Authors:	Alicia Isabel Pascual Pérez (Author), Gemma Pujol Muncunill (Author), Patricia Domínguez Sánchez (Author), Sara Feo Ortega (Author), Javier Martín de Carpi (Author)
Format:	Book
Published:	Elsevier, 2021-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Duración de la remisión sostenida tras el tratamiento de inducción con nutrición enteral exclusiva y azatioprina en pacientes con enfermedad de Crohn
by: Alicia Isabel Pascual Pérez, et al.
Published: (2021)

Prolonged remission of psoriasis with azathioprine pulse therapy
by: Ramji Gupta
Published: (2015)

Redox imbalance in Crohn's disease patients is modulated by Azathioprine
by: Mohammad Javad Tavassolifar, et al.
Published: (2021)

Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease
by: Kouzhu Zhu, et al.
Published: (2024)

HLA variants associated with azathioprine‐induced pancreatitis in patients with Crohn's disease
by: Joel Ås, et al.
Published: (2022)

Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction
by: Ana Luiza Vilar Guedes, et al.
Published: (2017)

ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN'S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
by: Ivaylo Vazharov, et al.
Published: (2016)

A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease
by: Víctor Manuel Navas-López, et al.
Published: (2018)

The use of enteral nutrition in pediatric patients with Crohn's disease
by: Bartosz Rudzki, et al.
Published: (2020)

Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine
by: Majed Aleissa, et al.
Published: (2017)

The SES-CD Could Be a Predictor of Short- and Long-Term Mucosal Healing After Exclusive Enteral Nutrition in Pediatric Crohn's Disease Patients
by: Wenjuan Tang, et al.
Published: (2022)

Vulval Intestinal/Enteric Heterotopia in a Patient with Crohn's Disease
by: Jean-Christophe Noël, et al.
Published: (2020)

Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn
by: Víctor Manuel Navas-López, et al.
Published: (2018)

A pilot study of the use of the oral and faecal microbiota for the diagnosis of ulcerative colitis and Crohn's disease in a paediatric population
by: A. Monleón-Getino, et al.
Published: (2023)

Hematological parameters and remission induction of childhood acute lymphoblastic leukemia
by: Roro Rukmi Windi Perdani, et al.
Published: (2018)

Azathioprine: its uses in dermatology,
by: Sonia Chavez-Alvarez, et al.
Published: (2020)

Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
by: Noriko Kimura, et al.
Published: (2019)

Eosinophilic fasciitis: a case series with an emphasis on therapy and induction of remission
by: Rechelle Tull, et al.
Published: (2018)

Azathioprine Hypersensitivity Syndrome in an Asian Woman
by: Li-En Tao, et al.
Published: (2020)

Rapid Remission With Upadacitinib in a Child With Refractory Crohn's Disease and ATM Mutation: A Case Report
by: Yan Liu, MD, et al.
Published: (2024)

Efektivitas Pemberian Nutrisi Enteral Eksklusif terhadap Induksi Remisi Penyakit Crohn
by: Muzal Kadim, et al.
Published: (2019)

APPLICATION EXPERIENCE OF THE ENTERAL FEEDING IN A PATIENT WITH THE STENOSING FORM OF CROHN'S DISEASE
by: O.V. Ryazanova, et al.
Published: (2007)

APPLICATION EXPERIENCE OF THE ENTERAL FEEDING IN A PATIENT WITH THE STENOSING FORM OF CROHN'S DISEASE
by: O.V. Ryazanova, et al.
Published: (2007)

A New Look at the Mechanisms of Remission Induction of Allergic Diseases in the Treatment with Allergens
by: S.M. Nedelska, et al.
Published: (2013)

Risk factors affecting relapse after discontinuation of biologics in children with Crohn's disease who maintained deep remission
by: Hansol Kim, et al.
Published: (2024)

Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn’s Disease
by: Chen R, et al.
Published: (2021)

Acute generalized exanthematous pustulosis secondary to azathioprine
by: Prasanta Basak, et al.
Published: (2015)

Drug Hypersensitivity due to Azathioprine with Elevated Procalcitonin
by: Tania Ahuja, et al.
Published: (2018)

Perforating dermatosis in a patient receiving azathioprine
by: Emiliano Grillo, et al.
Published: (2013)

Patient perception of bowel urgency and remission in moderately to severely active Crohn's disease or ulcerative colitis: a qualitative study
by: Theresa Hunter Gibble, et al.
Published: (2024)

Determination of azathioprine in bulk and pharmaceutical dosage form by HPTLC
by: Pritam S Jain, et al.
Published: (2012)

Azathioprine in inflammatory bowel disease, a safe alternative?
by: A. A. Tanis
Published: (1998)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
by: Koné-Paut I, et al.
Published: (2011)

Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
by: Eréndira Mejía-Aranguré, et al.
Published: (2022)

Initial steroid regimen in idiopathic nephrotic syndrome can be shortened based on duration to first remission
by: Hee Sun Baek, et al.
Published: (2015)

Azathioprine treatment in two children with Henoch-Schönlein purpura nephritis
by: Meltem A. Melikoğlu, et al.
Published: (2017)

Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment
by: Stephen P. Erickson, BS, et al.
Published: (2018)

Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study
by: Jessica Cusato, et al.
Published: (2021)

Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings
by: Motohiro Okayasu, et al.
Published: (2019)

Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia
by: Hikari Ambara Sjakti, et al.
Published: (2021)